Gabriel Ettenson is a US resident, based in the state of Colorado, where decriminalization efforts for psilocybin have already begun. He has a Bachelor’s degree in Biology and Psychology as well as a Master’s degree from Columbia University in Physical Therapy and Rehabilitation.
Professionally, Gabriel has owned and operated several mind/body-based businesses, including one of the largest integrative rehabilitation clinics on New York City’s prestigious Upper East Side. He was a co-founder of Elixinol, one of the first hemp-CBD companies in the world, where he served in the capacity of both President (US entity) and Chief Technology Officer (Global entity). He currently serves as Senior Innovation Strategist at Zilis, LLC where he focuses on product development based on advancing endocannabinoid science.